Sophia Antipolis, France.
Nicox S.A. (NYSE Euronext Paris: COX) today announced it has established a new Scientific Advisory Board (SAB) with international Key Opinions Leaders (KOLs) in the ophthalmology field. The first SAB meeting will be held on November 14, 2013 in New Orleans, Louisiana, United States, with the objective of evaluating the existing data on second generation nitric oxide (NO)-donors and discussing their potential therapeutic use in certain ophthalmic disorders.
Nicox’s SAB will be led by Dr. Richard L. Lindstrom, founder and attending surgeon at Minnesota Eye Consultants and Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology. Dr. Lindstrom is an internationally recognized leader in corneal, cataract, refractive and laser surgery.
Nicox will attend the 2013 Annual Meeting of the American Academy of Ophthalmology (AAO), taking place from November 16 to 18, 2013 in New Orleans, Louisiana, United States. Nicox can be found at booth number 4719. Nicox’s US and European operational teams will attend the meeting, as well as several members from the Executive team.